DK1753431T3 - Farmaceutisk sammensætning omfattende ZD6474 - Google Patents

Farmaceutisk sammensætning omfattende ZD6474

Info

Publication number
DK1753431T3
DK1753431T3 DK05744858T DK05744858T DK1753431T3 DK 1753431 T3 DK1753431 T3 DK 1753431T3 DK 05744858 T DK05744858 T DK 05744858T DK 05744858 T DK05744858 T DK 05744858T DK 1753431 T3 DK1753431 T3 DK 1753431T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DK05744858T
Other languages
Danish (da)
English (en)
Inventor
Paul William Stott
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1753431T3 publication Critical patent/DK1753431T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK05744858T 2004-05-21 2005-05-18 Farmaceutisk sammensætning omfattende ZD6474 DK1753431T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0411378.3A GB0411378D0 (en) 2004-05-21 2004-05-21 Pharmaceutical compositions
PCT/GB2005/001931 WO2005112934A1 (en) 2004-05-21 2005-05-18 Pharmaceutical compositions comprising zd6474

Publications (1)

Publication Number Publication Date
DK1753431T3 true DK1753431T3 (da) 2009-11-16

Family

ID=32607743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05744858T DK1753431T3 (da) 2004-05-21 2005-05-18 Farmaceutisk sammensætning omfattende ZD6474

Country Status (34)

Country Link
US (1) US8067427B2 (sr)
EP (1) EP1753431B1 (sr)
JP (1) JP4740947B2 (sr)
KR (1) KR101192935B1 (sr)
CN (1) CN101031303B (sr)
AR (2) AR049059A1 (sr)
AT (1) ATE439841T1 (sr)
AU (1) AU2005244650B2 (sr)
BR (1) BRPI0511253B8 (sr)
CA (1) CA2565513C (sr)
CY (1) CY1109500T1 (sr)
DE (1) DE602005016105D1 (sr)
DK (1) DK1753431T3 (sr)
ES (1) ES2330025T3 (sr)
GB (1) GB0411378D0 (sr)
HK (1) HK1099220A1 (sr)
HR (1) HRP20090547T1 (sr)
IL (1) IL178928A (sr)
ME (2) ME02778B (sr)
MX (1) MXPA06013501A (sr)
MY (1) MY138868A (sr)
NO (1) NO338324B1 (sr)
NZ (1) NZ550931A (sr)
PL (1) PL1753431T3 (sr)
PT (1) PT1753431E (sr)
RS (1) RS51112B (sr)
RU (1) RU2383343C2 (sr)
SA (1) SA05260133B1 (sr)
SI (1) SI1753431T1 (sr)
TW (1) TWI355269B (sr)
UA (1) UA81732C2 (sr)
UY (1) UY28901A1 (sr)
WO (1) WO2005112934A1 (sr)
ZA (1) ZA200609110B (sr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2278511B1 (es) * 2005-07-28 2008-06-16 Laboratorios Almirall S.A. Comprimidos con perfil de disolucion mejorado.
PT3039424T (pt) 2013-08-28 2020-09-03 Crown Bioscience Inc Taicang Assinaturas de expressão genética que permitem prever a resposta de um sujeito a um inibidor multiquinase e métodos de utilização do mesmo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718972D0 (en) * 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
PT1244647E (pt) 1999-11-05 2006-10-31 Astrazeneca Ab Derivados de quinazolina como inibidores de vegf
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
KR100419555B1 (ko) * 2000-05-29 2004-02-19 주식회사유한양행 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
WO2003074045A1 (fr) * 2002-03-05 2003-09-12 Eisai Co., Ltd. Agent antitumoral comprenant une combinaison d'un compose heterocyclique contenant un sulfamide et d'un inhibiteur d'angiogenese

Also Published As

Publication number Publication date
HK1099220A1 (en) 2007-08-10
TWI355269B (en) 2012-01-01
US20070244323A1 (en) 2007-10-18
NZ550931A (en) 2009-05-31
HRP20090547T1 (en) 2009-11-30
KR20070034499A (ko) 2007-03-28
CY1109500T1 (el) 2014-08-13
NO20065735L (no) 2006-12-19
AU2005244650B2 (en) 2008-04-10
US8067427B2 (en) 2011-11-29
AR110045A2 (es) 2019-02-20
PL1753431T3 (pl) 2009-12-31
MY138868A (en) 2009-08-28
CA2565513C (en) 2010-10-19
AR049059A1 (es) 2006-06-21
UA81732C2 (ru) 2008-01-25
CA2565513A1 (en) 2005-12-01
EP1753431A1 (en) 2007-02-21
BRPI0511253B1 (pt) 2020-03-31
TW200612953A (en) 2006-05-01
ES2330025T3 (es) 2009-12-03
EP1753431B1 (en) 2009-08-19
MXPA06013501A (es) 2007-06-12
ME02778B (me) 2010-10-31
CN101031303B (zh) 2011-08-31
IL178928A0 (en) 2007-03-08
BRPI0511253A (pt) 2007-11-27
SA05260133B1 (ar) 2008-12-23
RU2383343C2 (ru) 2010-03-10
PT1753431E (pt) 2009-10-14
RU2006145357A (ru) 2008-06-27
SI1753431T1 (sl) 2009-12-31
ZA200609110B (en) 2008-06-25
GB0411378D0 (en) 2004-06-23
RS51112B (sr) 2010-10-31
JP2007538060A (ja) 2007-12-27
DE602005016105D1 (de) 2009-10-01
WO2005112934A1 (en) 2005-12-01
ATE439841T1 (de) 2009-09-15
KR101192935B1 (ko) 2012-10-18
BRPI0511253B8 (pt) 2021-05-25
JP4740947B2 (ja) 2011-08-03
NO338324B1 (no) 2016-08-08
ME01505B (me) 2014-04-20
CN101031303A (zh) 2007-09-05
AU2005244650A1 (en) 2005-12-01
IL178928A (en) 2012-04-30
UY28901A1 (es) 2005-12-30

Similar Documents

Publication Publication Date Title
BRPI0511900A (pt) composições farmacêuticas
RU2398586C3 (ru) Фармацевтическая композиция
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
DK1725218T3 (da) Farmaceutisk sammensætning omfattende pimobendan
IL177480A0 (en) Pharmaceutical composition
DK2033629T3 (da) Fast farmaceutisk sammensætning omfattende valsartan
DK1587478T3 (da) Farmaceutisk sammensætning
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
MA28801B1 (fr) Composition antihistaminique
MA28603B1 (fr) Composition pharmaceutique antimycobacterienne
BRPI0614413A2 (pt) composto, e, composição farmacêutica
DK1784174T3 (da) Famaceutisk sammensætning omfattende gabapentin
BRPI0614412A2 (pt) composto, e, composição farmacêutica
HU0401177D0 (en) Pharmaceutical composition
GB2411355B (en) Pharmaceutical composition
ZA200701932B (en) Pharmaceutical composition
GB0425255D0 (en) Pharmaceutical composition
FR2871686B1 (fr) Composition anti-decoloration
DK1753431T3 (da) Farmaceutisk sammensætning omfattende ZD6474
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
ZA200701931B (en) Pharmaceutical composition
HUP0401176A2 (en) Pharmaceutical composition having prpkinetic effect
NO20042027D0 (no) Oral composition
GB0402799D0 (en) Pharmaceutical composition
SE0402637D0 (sv) Pharmaceutical use